+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Adocia - logo

Adocia is a biotechnology company which focuses on producing treatments for diabetes. It was founded in 2005, and headquartered in Lyon, France. The Company develops a BioChaperone Platform used for therapeutic protein delivery in regenerative medicine and chronic disease areas. There pipeline of products include: Biochaperone Lispro, Biochaperone Combo, Hinsbet, Biochaperone Human Glucagon, Biochaperone Glargine GLP-1, Biochaperone Prandial combinations for T1D.

Short Bowel Syndrome Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Short Bowel Syndrome Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • July 2018
  • 79 Pages
From
Short Bowel Syndrome - Pipeline Insight, 2021 - Product Thumbnail Image

Short Bowel Syndrome - Pipeline Insight, 2021

  • Clinical Trials
  • December 2021
  • 60 Pages
From
From
Loading Indicator